None
Quote | Cornerstone Strategic Value Fund Inc. (NYSE:CLM)
Last: | $7.17 |
---|---|
Change Percent: | 0.41% |
Open: | $7.2 |
Close: | $7.17 |
High: | $7.25 |
Low: | $7.11 |
Volume: | 1,554,418 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Cornerstone Strategic Value Fund Inc. (NYSE:CLM)
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Anthony S. Gibney has been appo...
2024-04-10 12:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Cornerstone Strategic Value Fund Inc. (NYSE:CLM)
Subject | By | Source | When |
---|---|---|---|
Anyone know about the upcoming$ CLM & $CFP | towerclimber92 | investorshub | 04/07/2015 7:20:28 AM |
Fluctuates? You mean steadily declines because the payout | bar1080 | investorshub | 01/21/2015 3:34:50 AM |
IMO it's still pays out good from divi. | globalprince | investorshub | 01/07/2015 11:30:08 PM |
Yuck. The only reason I was interested in | towerclimber92 | investorshub | 01/07/2015 11:14:52 PM |
Yeah it did | globalprince | investorshub | 01/07/2015 9:00:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Cornerstone Strategic Value Fund Inc. Company Name:
CLM Stock Symbol:
NYSE Market:
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that Anthony S. Gibney has been appo...
2024-04-10 12:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that George Lasezkay, Pharm.D., J.D....